default author photo

Soumya Hunagund

University of California, San Francisco (UCSF) - Division of Maternal Fetal Medicine

SCHOLARLY PAPERS

1

DOWNLOADS

143

TOTAL CITATIONS

0

Scholarly Papers (1)

Milk Antibody Response after 3rd Dose of COVID-19 mRNA Vaccine and SARS-CoV-2 Breakthrough Infection and Implications for Infant Protection

Number of pages: 19 Posted: 14 Nov 2022
University of California, San Francisco (UCSF) - Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco (UCSF), School of Medicine, Division of Hematology/Oncology, Department of Pediatrics, University of California, San Francisco (UCSF) - Department of Family Health Care Nursing, University of California, San Francisco (UCSF) - Division of Maternal Fetal Medicine, University of California, San Francisco (UCSF) - Division of Maternal Fetal Medicine, University of California, San Francisco (UCSF) - Division of Maternal Fetal Medicine, University of California, San Francisco (UCSF) - Center for Reproductive Sciences, University of California, San Francisco (UCSF) - Division of Maternal Fetal Medicine, University of California, San Francisco (UCSF) - Division of Maternal Fetal Medicine, University of California, San Francisco (UCSF) - Department of Family Health Care Nursing, University of California, San Francisco (UCSF) - Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco (UCSF), School of Medicine, Division of Hematology/Oncology, Department of Pediatrics, University of California, San Francisco (UCSF) - Division of Maternal Fetal Medicine and University of California, San Francisco (UCSF), School of Medicine, Division of Hematology/Oncology, Department of Pediatrics
Downloads 115 (620,578)

Abstract:

Loading...

Human milk, Antibody, vaccine, COVID-19, infection, immunity, mucosal immunity, Infants, Pediatrics, Lactation, ELISA

Milk Antibody Response After 3rd Dose of COVID-19 mRNA Vaccine and SARS-CoV-2 Breakthrough Infection and Implications for Infant Protection

Number of pages: 19 Posted: 29 Dec 2022
University of California, San Francisco (UCSF) - Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco (UCSF), School of Medicine, Division of Hematology/Oncology, Department of Pediatrics, University of California, San Francisco (UCSF) - Department of Family Health Care Nursing, University of California, San Francisco (UCSF) - Division of Maternal Fetal Medicine, University of California, San Francisco (UCSF) - Division of Maternal Fetal Medicine, University of California, San Francisco (UCSF) - Division of Maternal Fetal Medicine, University of California, San Francisco (UCSF) - Center for Reproductive Sciences, University of California, San Francisco (UCSF) - Division of Maternal Fetal Medicine, University of California, San Francisco (UCSF) - Division of Maternal Fetal Medicine, University of California, San Francisco (UCSF) - Department of Family Health Care Nursing, University of California, San Francisco (UCSF) - Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco (UCSF), School of Medicine, Division of Hematology/Oncology, Department of Pediatrics, University of California, San Francisco (UCSF) - Division of Maternal Fetal Medicine and University of California, San Francisco (UCSF), School of Medicine, Division of Hematology/Oncology, Department of Pediatrics
Downloads 28 (1,385,838)

Abstract:

Loading...